৳ 0.00
Your Complete HealthCare Solution - Right Here
10657
info@shukhee.com
Telecom Bhaban (Level- 12), 53/1 Box Nagar, Zoo Road, Dhaka-1216.
৳ 0.00
10657
info@shukhee.com
Telecom Bhaban (Level- 12), 53/1 Box Nagar, Zoo Road, Dhaka-1216.


Quantity:
Products
Payment
Delivery
Ruvan-Z is a combination of Rosuvastatin (an HMG-CoA reductase inhibitor or statin) and Ezetimibe (a cholesterol absorption inhibitor). It is indicated in adults as an adjunct to diet for reducing LDL-cholesterol (bad cholesterol) in patients with primary non-familial hyperlipidaemia and for reducing LDL-cholesterol in patients with homozygous familial hypercholesterolaemia, either alone or in combination with other lipid-lowering therapies.
Rosuvastatin works by reducing cholesterol production in the liver and increasing the number of LDL receptors, which enhances the removal of LDL from the bloodstream. Ezetimibe lowers blood cholesterol by inhibiting cholesterol absorption in the small intestine. Together, they provide an effective dual mechanism for cholesterol reduction.
The recommended dosage ranges from 5 mg/10 mg to 40 mg/10 mg once daily, depending on the patient's LDL-C level, treatment goals, and cardiovascular risk profile. Patients with severe renal impairment not undergoing haemodialysis should begin with 5 mg/10 mg once daily and should not exceed 10 mg/10 mg daily. Tablets should be swallowed whole and must not be crushed, chewed, or dissolved.
Concomitant use with Cyclosporine or Gemfibrozil is not recommended. Dose adjustments may be required when used with certain antiviral medicines, Darolutamide, or Regorafenib. Niacin, fibrates, and colchicine may increase the risk of muscle-related adverse effects.
The medicine is contraindicated in patients with active liver disease, decompensated cirrhosis, or hypersensitivity to any component of the formulation.
Common side effects include headache, nausea, muscle pain, joint pain, dizziness, weakness, constipation, abdominal pain, diarrhoea, sinusitis, respiratory tract infections, fatigue, influenza-like symptoms, pain in extremities, and back pain.
Ruvan-Z is contraindicated during pregnancy and is not recommended during breastfeeding.
Important precautions include the risk of myopathy and rhabdomyolysis, especially in elderly patients, those with uncontrolled hypothyroidism, renal impairment, or those receiving higher doses and interacting medicines. Liver enzyme monitoring may be considered before and during treatment when clinically indicated. Patients with severe liver impairment or acute liver failure should not use this medication.
Drug Class
Combination of a statin (Rosuvastatin) and a cholesterol absorption inhibitor (Ezetimibe).
Belongs to the class of lipid-lowering agents.
Purpose
Used to treat hyperlipidemia (high cholesterol).
Helps reduce LDL cholesterol (“bad cholesterol”) more effectively than either drug alone.
Prescribed to lower the risk of heart attack, stroke, and other cardiovascular diseases.
Mechanism
Rosuvastatin: Blocks HMG-CoA reductase in the liver, reducing cholesterol production.
Ezetimibe: Prevents absorption of cholesterol from the intestine.
Together, they provide dual action—less cholesterol made in the liver and less absorbed from food.
Advantages
Stronger LDL reduction: More effective than statin alone.
Convenient combination: Two medicines in one tablet reduce pill burden.
Cardiovascular protection: Helps prevent complications in patients with high cholesterol or existing heart disease.
Well tolerated: Generally safe with proper monitoring.
Dose:
Commonly available as Rosuvastatin (5–20 mg) + Ezetimibe (10 mg) tablets.
Usual dose: Once daily, taken with or without food.
Exact dosage must be prescribed by a doctor depending on cholesterol levels and patient condition.




Stronger LDL reduction: Lowers “bad cholesterol” (LDL) more effectively than statin alone.
Dual mechanism: Rosuvastatin reduces cholesterol production in the liver, while Ezetimibe blocks absorption from food.
Cardiovascular protection: Helps reduce risk of heart attack, stroke, and other complications.
Convenient combination: Two medicines in one tablet, reducing pill burden.
Improves treatment response: Useful for patients who do not reach target cholesterol levels with statin alone.
Well tolerated: Generally safe with proper monitoring of liver function and muscle health.





